Scientists develop first anti-malaria drug in 25 years | The IndependentNotifications can be managed in browser preferences.Jump to contentIndependentSwipe for next articleIndependent Bulletin homepageDownload ourSocial PartnerWe are 8 logo (opens in a new tab)AllNewsSportCultureLifestyleMaryam Zakir-HussainThursday 13 November 2025 01:21 GMTWhat to know about malariaScientists have developed GanLum, a new anti-malaria drug, the first in 25 years, which has shown a cure rate of over 97 per cent in trials.Developed by Novartis, the treatment works by disrupting the malaria parasite's internal protein transport system, which is crucial for its survival.GanLum was created to combat emerging resistance to existing anti-malaria treatments, and also has the potential to block disease transmission.A large clinical trial involved 1,700 adults and children across 34 sites in 12 Sub-Saharan African countries, with findings presented at a meeting in Toronto.Experts describe the drug as potentially “the biggest advance in malaria treatment for decades” due to its high efficacy against multiple forms of the parasite and resistant strains.In fullScientists unveil new anti-malaria drug with ‘very high cure rate’Thank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in